Commercialization Pathway Expands as Caleco Pharma Licenses Five Compounds for ... CNNMoney.com (press release) Caleco Pharma is focused on the ongoing research and development of its pipeline of over-the-counter and prescription medications including its proprietary ...

MiddleBrook Pharmaceuticals Announces Expanded IncreaseRx(R) Promotion for ... MarketWatch (press release) IncreaseRx(R) utilizes a suite of traditional and web-based tactics to generate incremental revenue for any pharmaceutical brand regardless of product life ...

2point6billion Drug sales in emerging mkts to soar: study Business Standard "These traditionally peripheral economies are gearing up to turn the tables on the established pharmaceutical world order," IMS Health said. ... IMS: China to be 3rd largest pharma market in 2011 Emerging Markets To Make Half Of Pharma Sales Growth By '13 Study Report: China to be 3rd largest pharma market by 2011

Woodlands Online, LLC Lexicon Pharma Shares Drop After Public Stock Offering RTT News (RTTNews) - Biopharmaceutical company Lexicon Pharmaceuticals Inc.'s (LXRX: News ) shares dropped 9.86% on Tuesday following the news that the company ... Lexicon Pharma to sell stock to public and its largest shareholder, raise ... Lexicon Pharma Announces Pricing Of Common Stock In Public Offering - Quick Facts

Hikma Pharma sees low-teens sales growth in 2010 Reuters LONDON, March 17 (Reuters) - Jordan-based Hikma Pharmaceuticals (HIK.L) expects to grow sales in the "low-teens" percent in 2010, ... Hikma Pharma FY09 Profit Up - Quick Facts Sector movers: Hikma weighs on pharma sector STOCKS NEWS EUROPE-Hikma down on outlook; broker downgrade

' Pharma parties' a troubling trend among youths Seattle Post Intelligencer Joe and his friends had discovered the seductive wonder of " pharma parties" - and before long, the horror of addiction. Pharma parties, where kids get ...

JAPAN'S ASTELLAS FACES PRESSURE TO SWEETEN BID FOR OSI PHARMA Trading Markets (press release) Speculation has emerged that Japan's Astellas Pharma Inc. (TSE:4503) will raise its bid for US drugmaker OSI Pharmaceuticals Inc. In response to OSI ... OSI Pharmaceuticals Comments on Astellas' Slate of Director Nominees OSI Pharmaceuticals rejects Astellas $3.5-billion hostile bid Astellas nominates board in OSI takeover bid - -

Reuters Portola Pharma : The next big thing? Bizjournals.com (blog) Will Portola, spun out of Millennium Pharmaceuticals ' 2001 deal for Cor Therapeutics Inc., go public? In Portola's case it may not matter: Its managers have ... Portola Pharma , Merck Say Betrixaban Reduced Incidence Of Bleeding Vs ... Portola Pharma And Merck Announce Results Of EXPLORE-Xa - Quick Facts

Simcere Pharma 4Q Profit Falls 66% On Higher Costs »SCR Wall Street Journal Simcere Pharmaceutical Group's (SCR) fourth-quarter earnings dropped by two-thirds as the Chinese pharmaceutical company saw higher costs that more than ... Simcere Pharma Misses on Earnings, Top Line Up 16.6% (SCR) Simcere Pharma Q4 Profit Falls - Update Simcere Pharma Misses on Earnings, Top Line Up 16.6% (SCR)

Triangle Business Journal Inspire Pharma falls on Azasite study failures BusinessWeek Shares of Inspire Pharmaceuticals Inc. slipped Monday after the company said its eye drug Azasite did not meet its goals in a pair of clinical trials. ... Inspire Pharma eye drug fails in mid-stage study Inspire Pharma's Eye Drug Disappoints In Mid-stage Trials - Update Inspire Pharma Shares Down 6.5% After Eye Drug Didn't Achieve Significant ...